))
Focus on the PARITY Trial, with special guest Michelle Ghert, MD, FRCSC
Manage episode 441997061 series 3411677
Content provided by Paul Sandford, Mohit Bhandari, and Marc Swiontkowski. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Paul Sandford, Mohit Bhandari, and Marc Swiontkowski or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode, Marc and Mo are joined by special guest Michelle Ghert, MD, FRCSC (Professor of Surgery at McMaster University and President of the Musculoskeletal Tumor Society) in a discussion of the Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) study that appeared in JAMA as well as the related JBJS supplement focusing on secondary analytic questions.
Links:
- PARITY Supplement in JBJS: https://bit.ly/47fEkqH
- Editorial focusing on PARITY: https://bit.ly/44ExN6Z
- Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) Investigators; Ghert M, Schneider P, Guyatt G, Thabane L, Vélez R, O'Shea T, Randall RL, Turcotte R, Wilson D, Wunder JS, Baptista AM, Cheng EY, Doung YC, Ferguson PC, Giglio V, Hayden J, Heels-Ansdell D, Khan SA, Sampath Kumar V, McKay P, Miller B, van de Sande M, Zumárraga JP, Bhandari M. Comparison of Prophylactic Intravenous Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors: A Randomized Clinical Trial. JAMA Oncol. 2022 Mar 1;8(3):345-353. doi: 10.1001/jamaoncol.2021.6628. PMID: 34989778; PMCID: PMC8739829. https://bit.ly/3K7MG8S
Subspecialties:
- Infection
- Oncology
- Orthopaedic Essentials
100 episodes
Share
